Therefore, we studied the expression of β7 on uncultured immune-reactive cells from AML patients and healthy blood donors (as a control), generated DC/DCleu from healthy and leukemic samples and studied their potential to activate (β7-expressing) immune-reactive cells after T-cell-enriched MLC. The gene discussed is CD80; the disease is acute myeloid leukemia.